Not yet recruiting
PET-CT in Lymphoma Among the Eldery
NCT07259941
- Conditions
- Elderly, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
Not specified
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,146 public trials
2,034 recruiting studies
Lymphoproliferative Disorders trial results
NCT07259122
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- China Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences Tianjin, China
- Institute of Hematology & Blood Diseases Hospital, China Tianjin, Tianjin Municipality, China
Not yet recruiting
Allogeneic UCB-derived CAR-T for B-ALL
NCT07256353
- Conditions
- B-Cell Acute Lymphoblastic Leukemia, Adult, Burkitt Lymphoma, DNA Virus Infections, +15 more
- Locations
-
- The General Hospital of Western Theater Command Chengdu, Sichuan, China
NCT07253103
- Conditions
- Behavior, Blood Protein Disorders, Cancer, +17 more
- Locations
-
Not specified
Not yet recruiting
Study Evaluating the Efficacy and Tolerance of a Zanubrutinib and BGB-11417 Combination in Patients Previously Treated for Waldenström Macroglobulinemia
NCT06547866
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- AMIENS - CH Amiens Picardie Site Sud Amiens, France
- Angers Chu Angers, France
- ANNECY - CH Annecy Genevois Annecy, France
- ARGENTEUIL - Centre hospitalier Victor Dupouy Argenteuil, France
Not yet recruiting
Phase II Trial of S101 Autologous Anti-CD7 CAR-T Cells in Patients With R/R T-LBL/ALL.
NCT07244380
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
Not specified
Not yet recruiting
A Clinical Study to Explore CT1195E in Patients With Relapsed/Refractory B-Cell Neoplasms
NCT07234045
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
- Locations
-
- China Institute of Hematology and Blood Diseases Hospital Tianjin, Tianjin Municipality, China
NCT07213882
- Conditions
- Cutaneous T Cell Lymphoma (CTCL), Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
Not specified
Not yet recruiting
Combination Therapy With Tazemetostat in Relapsed and Refractory Peripheral T-cell Lymphoma
NCT07209163
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
Not specified
Not yet recruiting
PirtobrUtinib as Frontline Therapy for Elderly Unfit/Frail Patient With MAntle Cell Lymphoma
NCT07207785
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- IRCCS Istituto Romagnolo per lo studio dei Tumori "Dino Amadori" - IRST S.R.L. - Ematologia Meldola, Forlì-Cesena, Italy
- Istituto Clinico Humanitas - U.O. Ematologia Rozzano, Milano, Italy
- AOU Ospedali Riuniti - Clinica di Ematologia Ancona, Italy
- Azienda Ospedaliera S.Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico Avellino, Italy